Sun Pharma Advanced Research Co. Ltd. Financial Overview
Sun Pharma Advanced Research Co. Ltd.'s market cap is currently ₹43.10B. The company's EPS TTM is ₹-2.337; its P/E ratio is -15.93; Sun Pharma Advanced Research Co. Ltd. is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
